Custom Synthesis

Introduction to Regulatory Expectations for Peptide-Oligonucleotide Conjugates in IND Submissions The regulatory pathway for advancing Peptide-Oligonucleotide Conjugates (POCs) in Investigational […]

Introduction The successful clinical development and regulatory approval of hybrid biotherapeutics depend on advanced analytical strategies for the Structural Characterization

The development and clinical advancement of hybrid biotherapeutics relies heavily on specialized HPLC Purification Services for Peptide-Oligonucleotide Conjugates that can

Introduction: The convergence of peptide chemistry and oligonucleotide biology has produced one of the most promising — and analytically demanding

Introduction to Mass Spectrometry Characterization of Peptide-Oligonucleotide Conjugates Mass spectrometry characterization of peptide-oligonucleotide conjugates is a sophisticated, multi-dimensional analytical approach

Peptide-oligonucleotide conjugates (POCs) have emerged as an innovative class of chimeric therapeutics that integrate the exceptional sequence specificity of nucleic

What is the Scope of a CRO in IND-Enabling Studies for Peptide Oligonucleotide Conjugates? A specialized Contract Research Organization (CRO)

Introduction: GMP manufacturing of peptide-oligonucleotide conjugates sits at the intersection of two highly complex chemistries — and getting it right

Introduction: Peptide-Oligonucleotide Conjugates Impurity Profiling plays a critical role in the development of next-generation therapeutics such as antisense oligonucleotides, RNA